Every Form 4 that Agilent Technologies Inc. (A) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow A and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full A filings page.
AGILENT TECHNOLOGIES, INC. (symbol: A) is the issuer of record for a Form 4 filing submitted to the SEC. Boehnlein Glenn S reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. (A) reported that director Glenn S. Boehnlein received an award of 817 shares of common stock on September 8, 2026, described as common stock for Non-Employee Directors that is fully vested upon grant at a reference value of $146.85 per share. Following this grant, Boehnlein holds 817 shares directly, and an additional 35 shares are held indirectly through the Boehnlein 2017 Trust, for which Glenn and Susan Boehnlein serve as trustees. No transactions were reported under a Rule 10b5-1 trading plan.
AGILENT TECHNOLOGIES, INC. (A) director Mikael Dolsten reported selling 634 shares of common stock on September 4, 2026, in an open-market or private transaction at $151.375 per share. After this sale, he held 4,923.680 shares directly, including 9.295 shares acquired through a dividend reinvestment plan and deferred. No Rule 10b5-1 trading plan is reported for this transaction.
Agilent Technologies Senior Vice President Jonah Prevost Kirkwood reported a small, routine share disposition related to taxes on equity compensation. He surrendered 30 shares of common stock to Agilent at $136.01 per share to cover the tax liability on vesting restricted stock units under Rule 16b-3. Following this tax-withholding transaction, he directly holds 14,108 shares of Agilent common stock.
AGILENT TECHNOLOGIES, INC. President and CEO Padraig McDonnell reported a routine share disposition related to taxes. He surrendered 418 shares of common stock to Agilent to satisfy the tax liability on the vesting of restricted stock units, as allowed under Rule 16b-3. After this tax-withholding transaction, he holds 65,842 shares of Agilent common stock directly.
Agilent Technologies director Mikael Dolsten sold 1,600 shares of common stock in an open-market transaction at $135.42 per share. After this sale, he directly holds 5,548.385 shares. This balance includes 10.175 shares acquired through Agilent’s dividend reinvestment plan, which he has elected to defer.
Buckner Michael Steven reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. Senior Vice President Michael Steven Buckner received an equity compensation award reported on Form 4. He was granted 8,872 restricted stock units under the Agilent Technologies, Inc. 2018 Stock Plan, with no cash paid per unit.
The restricted stock units vest in four equal annual installments beginning on May 19, 2027, meaning the award will fully vest over four years if conditions are met. Following this grant, Buckner directly holds 8,887 shares of Agilent common stock, reflecting a relatively modest ownership position for a senior executive.
Agilent Technologies Senior Vice President Simon May surrendered 368 shares of common stock on May 8, 2026 at $115.62 per share to cover tax obligations on the vesting of restricted stock units. This was a tax-withholding disposition, not an open-market sale. After the transaction, May directly holds about 14,015.487 shares, which include 3.457 shares acquired through a dividend reinvestment plan and 172.7831 shares acquired through an employee stock purchase plan.
AGILENT TECHNOLOGIES, INC. Senior Vice President Meghan Henson had 153 shares of common stock surrendered to the company to cover tax withholding on the vesting of restricted stock units, based on a value of $113.98 per share. This was an administrative tax-withholding disposition, not an open-market trade. Following the transaction, she directly holds 6,890 shares of Agilent common stock.
Rataj Sue H. reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. director Sue H. Rataj received an award of 2,158 shares of common stock on March 19, 2026. The shares were granted as compensation for service as a non-employee director and were fully vested upon grant at a reference price of $111.75 per share. Following this award, she directly holds 23,617 shares of Agilent common stock.
Agilent Technologies director Otis W. Brawley received two awards of common stock on March 19, 2026, acquiring 2,158 and 888 shares as compensation grants at a reference price of $111.75 per share. These are non-employee director awards that are fully vested upon grant.
According to the footnotes, Brawley elected to defer receipt of these shares into a deferral account under Agilent’s deferred compensation arrangements, rather than taking the stock immediately. After these transactions, his directly held and deferred Agilent common stock position reported in this filing totals 13,873.623 shares.
AGILENT TECHNOLOGIES, INC. director George A. Scangos reported equity awards of common stock. On 2026-03-19, he received two grants of Agilent common stock as a non-employee director, covering 2,158 shares and 1,057 shares at a reference price of $111.75 per share.
The awards are fully vested upon grant, and he has elected to defer receipt of these shares into a deferral account under Agilent’s 2005 Deferred Compensation Plan for Non-Employee Directors. A footnote also states that 148.973 shares were acquired through Agilent’s dividend reinvestment plan and likewise deferred.
After these transactions, Scangos holds 23,857.047 Agilent shares directly in deferred accounts and an additional 17,893 shares indirectly through the George A. Scangos and Leslie S. Wilson Family Trust. These transactions reflect compensation and deferral elections rather than open-market buying or selling.
Agilent Technologies director Pascal Soriot reported a routine equity compensation event. He received 2,158 shares of Agilent common stock as a fully vested stock award for non-employee directors at a reference price of $111.75 per share. To cover tax obligations on the vesting of restricted stock units, he surrendered 648 shares back to Agilent under Rule 16b-3, a tax-withholding disposition rather than a market sale. After these transactions, he directly holds 2,683 shares of Agilent common stock.
Agilent Technologies director Wilson Dow reported receiving an award of 2,158 shares of common stock on March 19, 2026 at a reference price of $111.75 per share. This was a fully vested stock grant for non-employee directors, classified as a compensation-related acquisition rather than an open-market purchase.
After the award, Dow directly holds 20,368.606 shares of Agilent common stock. A footnote also states that 144.124 shares were acquired through the company’s dividend reinvestment plan and have been deferred by the reporting person.
Podolsky Daniel K reported acquisition or exercise transactions in this Form 4 filing.
Agilent Technologies director Daniel K. Podolsky received a grant of 2,158 shares of common stock valued at $111.75 per share. The award was made as compensation for non-employee directors and is fully vested upon grant. Podolsky elected to defer receipt of these shares, meaning delivery is postponed under Agilent’s deferral arrangements.
Following this award and prior dividend reinvestment activity noted in the footnotes, Podolsky now holds 38,179.908 shares of Agilent common stock in total.
Agilent Technologies director Koh Boon Hwee received an award of 2,158 shares of common stock valued at $111.75 per share as compensation for non-employee directors, fully vested upon grant. In connection with this award and vesting of restricted stock units, he surrendered 648 shares to Agilent to cover tax liabilities.
Footnotes note an additional 106.132 shares acquired through the dividend reinvestment plan, which he has elected to defer. After these transactions, Koh directly holds 63,184.351 shares of Agilent common stock.
Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings. He was granted 2,158 shares of Agilent common stock at a value of $111.75 per share as a fully vested award for non-employee directors. Following the grant, he directly holds 7,138.2100 shares of common stock. Dolsten elected to defer receipt of 1,079 of the granted shares, and an additional 7.182 shares were acquired and deferred through the company’s dividend reinvestment plan.
Agilent Technologies director Judy L. Brown received a stock award of 2,158 shares of common stock on March 19, 2026. The award for non-employee directors is fully vested upon grant and was valued at $111.75 per share. Following this grant, Brown directly owns 3,835 Agilent shares. This is a compensation-related share acquisition rather than an open-market purchase.
Agilent Technologies director receives stock award
Agilent Technologies director Mala Anand acquired 2,158 shares of common stock on an award valued at $111.75 per share. The footnote explains this was a fully vested stock grant for non-employee directors, meaning it is compensation, not an open-market purchase. After the award, Anand directly holds 16,705 Agilent shares.
Agilent Technologies Senior Vice President Angelica Riemann reported a small tax-related share disposition. On the vesting of restricted stock units, she surrendered 89 shares of common stock at $121.38 per share back to Agilent to cover tax liabilities under Rule 16b-3, rather than selling shares in the open market. After this transaction, she directly holds 26,535.1416 shares of Agilent common stock, and an additional 2,610.6966 shares are held indirectly through her spouse. Footnotes note modest additional shares previously acquired through Agilent’s dividend reinvestment plan.
AGILENT TECHNOLOGIES, INC. President and CEO Padraig McDonnell reported a tax-related stock transaction. On the vesting of restricted stock units, he surrendered 279 shares of common stock to Agilent at $121.38 per share to cover withholding taxes. Following this Rule 16b-3 tax-withholding disposition, he directly holds 66,260 shares of Agilent common stock.
Agilent Technologies Senior Vice President Jonah Prevost Kirkwood reported a small share disposition related to taxes, not an open-market sale. He surrendered 124 shares of common stock to Agilent Technologies, Inc. at a price of $121.38 per share to cover tax liabilities on vesting restricted stock units, leaving him with 14,138 shares held directly.
Agilent Technologies, Inc. reported an amendment to an insider ownership filing for its vice president and corporate controller. The officer’s directly held common stock was corrected to 32,153.3546 shares following previously reported transactions. The original report had shown 31,526.6872 shares, so this amendment adds back shares that were understated due to an administrative error. The company states that only the holdings total is revised and that there are no changes to the underlying transactions previously reported.
Agilent Technologies director reports stock sale. A director of Agilent Technologies, Inc. reported selling 2,600 shares of common stock on 12/01/2025 at a weighted average price of $149.812 per share, with individual sale prices ranging from $149.80 to $149.84. After this transaction, the director beneficially owns 4,973.028 shares of Agilent common stock. This total includes 23.092 shares acquired through the company’s dividend reinvestment plan in transactions exempt under Rule 16a-11, which the director has elected to defer.
Agilent Technologies’ senior vice president reported a routine share transaction related to equity compensation. On 11/26/2025, the executive surrendered 208 shares of Agilent common stock to the company at a price of $154.37 per share to cover tax withholding on vesting restricted stock units, as allowed under Rule 16b-3. After this tax-related share surrender, the reporting person beneficially owned 11,639.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. reported an insider equity transaction by a Senior Vice President. On 11/26/2025, the executive surrendered 280 shares of common stock to Agilent to satisfy tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. The shares were valued at $154.37 each for this tax withholding transaction.
After this event, the executive beneficially owned 26,593.9266 shares of Agilent common stock directly and 2,607.6856 shares indirectly through a spouse. This is an administrative tax-related transaction rather than an open-market purchase or sale.
Agilent Technologies, Inc. reported an insider transaction by its President and CEO, who is also a director. On 11/26/2025, the executive surrendered 1,948 shares of common stock to Agilent at $154.37 per share to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3.
After this tax-related share surrender, the executive beneficially owns 66,539 shares of Agilent common stock in direct ownership. This filing reflects a routine administrative transaction to satisfy taxes rather than an open-market sale.
Agilent Technologies, Inc. officer and Senior Vice President reported a routine equity transaction on Form 4. On 11/26/2025, the reporting person surrendered 300 shares of Agilent common stock to the company at a price of $154.37 per share to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related surrender, the reporting person beneficially owned 14,207.2469 shares of Agilent common stock, held directly.
Agilent Technologies executive reports small stock disposition for tax withholding
A Senior Vice President of Agilent Technologies, Inc. reported a routine share disposition related to equity compensation. On 11/26/2025, the executive surrendered 430 shares of Agilent common stock at a reported price of $154.37 per share, coded as an "F" transaction, meaning the shares were withheld to cover taxes on vesting restricted stock units. After this transaction, the executive beneficially owns 14,262 shares of Agilent common stock directly. No derivative securities transactions were reported in this filing.
Agilent Technologies executive Rodney Gonsalves, Vice President and Corporate Controller, reported multiple stock transactions in Agilent Technologies, Inc. common stock. On 11/26/2025, he sold 3,000 shares at a weighted average price of $154.9853 per share, with individual sale prices ranging from $154.98 to $155.05. He also surrendered 119 shares to Agilent to cover tax liabilities related to the vesting of restricted stock units.
That same day, Gonsalves reported several gift-related movements: transfers coded as gifts involving 200 shares connected to the Gonsalves Family Charitable Gift Fund and indirect holdings in the Gonsalves Trust. After these transactions, he directly owned 31,526.6872 shares of Agilent common stock and held 40.192 shares indirectly through the Gonsalves Trust.
Agilent Technologies reported an insider equity transaction by a senior vice president. On 11/26/2025, the executive surrendered 332 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. The shares were valued at $154.37 each for this tax withholding transaction. After this adjustment, the reporting person directly beneficially owns 12,203.056 shares of Agilent common stock.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 67 shares of Agilent common stock to the company at a price of $151.25 per share. This was done to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3, which governs certain insider transactions. After this tax-related share surrender, the executive beneficially owned about 11,847.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. (A) reported an insider transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 75 shares of common stock to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as allowed under Rule 16b-3. After this tax withholding, the executive directly beneficially owned 26,873.9266 shares of common stock and indirectly owned 2,607.6856 shares through a spouse.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by its President and CEO, who is also a director. On 11/21/2025, the executive surrendered 541 shares of common stock to Agilent at a price of $151.25 per share.
The filing explains that these shares were surrendered to the company to satisfy tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related share surrender, the executive directly beneficially owns 68,487 shares of Agilent common stock.
Agilent Technologies (A) reported an insider equity transaction by its Senior Vice President. On 11/21/2025, the executive surrendered 113 shares of common stock at a price of $151.25 per share to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After this tax-related share surrender, the reporting person beneficially owned 14,692 shares of Agilent common stock, held directly.
Agilent Technologies (ticker: A) officer reports routine tax share surrender. On 11/21/2025, the company’s V.P., Corporate Controller reported a Form 4 transaction coded “F,” meaning 138 shares of common stock were surrendered to Agilent Technologies, Inc. to cover taxes due on the vesting of restricted stock units. After this transaction, the reporting person beneficially owned 34,845.6872 shares of Agilent common stock directly and 40.192 shares indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees. This filing records an administrative tax-withholding event rather than an open-market trade.
Agilent Technologies (A) reported an equity award to a senior executive. A Senior Vice President received 6,922 shares of common stock in the form of restricted stock units on 11/18/2025 at a stated price of $0, reflecting that this is a stock-based compensation grant rather than an open-market purchase. These restricted stock units vest in four equal annual installments beginning on November 18, 2026, meaning the executive earns the shares over time if service conditions are met.
After this award, the executive beneficially owns 12,535.056 shares of Agilent common stock directly. This total includes 137.654 shares acquired through an Employee Stock Purchase Plan under Section 423 of the Internal Revenue Code in a transaction exempt under Rule 16b-3. The filing is made on Form 4 by a single reporting person in the capacity of officer.
Agilent Technologies, Inc. (A) reported insider equity activity for a Senior Vice President on a Form 4. On November 18, 2025, the executive received 1,421 shares of common stock at $0 under the Long-Term Performance Program, with a one-year holding requirement after vesting. On the same date, the executive surrendered 452 shares back to Agilent at $143.84 to cover taxes on vested restricted stock units. The executive was also granted 5,227 restricted stock units at $0 under the 2018 Stock Plan, which vest in four equal annual installments beginning on November 18, 2026. Following these transactions, the executive directly beneficially owned 11,914.0318 shares of Agilent common stock.
Agilent Technologies (A) reported insider equity awards and tax withholding for a senior vice president. On November 18, 2025, the executive received 1,493 shares of common stock under Agilent’s Long-Term Performance Program, which are subject to a one-year post-vest holding period. The executive also surrendered 489 shares back to Agilent at a price of $143.84 per share to cover taxes on vesting restricted stock units.
In addition, the executive was granted 6,781 restricted stock units under the 2018 Stock Plan, which vest in four equal annual installments beginning on November 18, 2026. Following these transactions, the executive beneficially owned 26,948.9266 shares directly, with an additional 2,607.6856 shares held indirectly through a spouse.
Agilent Technologies (A) president and CEO Michael McMullen reported several equity transactions on November 18, 2025. He sold 911 shares of common stock at $143.24 per share under a pre-arranged Rule 10b5-1 trading plan. On the same date, he received 7,104 shares of common stock issued under Agilent’s Long-Term Performance Program, which carry a 1-year post-vest holding period.
To cover taxes on vesting restricted stock units, he surrendered 3,474 shares back to Agilent at $143.84 per share. He was also granted 33,340 restricted stock units under the 2018 Stock Plan, vesting in four equal annual installments beginning November 18, 2026. After these transactions, he directly beneficially owned 69,028 shares of Agilent common stock.
Agilent Technologies (A) reported an equity grant to a senior executive. A Senior Vice President received 6,781 shares of common stock in the form of restricted stock units on 11/18/2025 at a stated price of $0, reflecting that this is an award rather than a market purchase.
The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan and will vest in four equal annual installments beginning on November 18, 2026. Following this grant, the reporting person beneficially owns 14,507.2469 shares of Agilent common stock, which includes 234.83 shares acquired through an Employee Stock Purchase Plan transaction that is exempt under Rule 16b-3.
Agilent Technologies (A) reported insider equity activity for a Senior Vice President on Form 4. On November 18, 2025, the executive received 1,438 shares of common stock at $0 under the company’s Long-Term Performance Program, with a 1-year post-vest holding period.
On the same date, the executive surrendered 772 shares at $143.84 to cover taxes on vested restricted stock units. The executive was also granted 6,075 restricted stock units under the 2018 Stock Plan, which vest in four equal annual installments starting on November 18, 2026. After these transactions, the executive directly owned 14,805 shares of Agilent common stock.
Agilent Technologies (ticker A) reported insider equity activity for its Vice President and Corporate Controller, Rodney Gonsalves. On November 18, 2025, he received 2,540 shares of common stock under Agilent’s Long-Term Performance Program, which are subject to a one-year holding period after vesting. On the same date, he surrendered 883 shares back to Agilent to cover tax liabilities related to vesting restricted stock units.
He also received 2,402 restricted stock units under the Agilent 2018 Stock Plan, which are scheduled to vest in four equal annual installments beginning November 18, 2026. Following these transactions, he beneficially owned 34,983.6872 shares directly, plus 40.192 shares held indirectly through the Gonsalves Trust, for which he and Rochelle Gonsalves serve as trustees.
Agilent Technologies, Inc. (A) reported a change in ownership by a senior vice president on a Form 4. On November 18, 2025, the officer received 5,368 shares of common stock through a grant of restricted stock units at a stated price of $0, reflecting an equity award rather than a market purchase. Following this grant, the reporting person beneficially owned 7,043 shares directly.
The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan and are scheduled to vest in four equal annual installments beginning on November 18, 2026, meaning the officer will gain full access to the shares over a four-year period if vesting conditions are met.
Agilent Technologies (ticker: A) reported a stock-based award to its Senior Vice President and Chief Financial Officer. On 11/18/2025, the executive received 11,726 shares of common stock in the form of restricted stock units granted under the Agilent Technologies, Inc. 2018 Stock Plan. The award was reported at a price of $0, reflecting that this is an equity grant rather than an open-market purchase.
The restricted stock units will vest in four equal annual installments beginning on November 18, 2026, meaning the executive will receive portions of the shares over four years as long as the vesting conditions are met. This type of compensation is commonly used to align executive incentives with long-term company performance.
Agilent Technologies, Inc. (A) reported an insider equity transaction by a Senior Vice President in a Form 4. On 11/14/2025, the executive surrendered 27 shares and 51 shares of common stock back to Agilent at a price of $146.82 per share. These shares were withheld to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After these routine tax-related transactions, the reporting person beneficially owned 5,769.0318 and then 5,718.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. reported an insider equity transaction by a senior executive. A Senior Vice President filed a Form 4 showing two tax-related share surrenders on 11/14/2025. The executive surrendered 44 shares and 56 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, in transactions reported under Rule 16b-3.
After these transactions, the executive beneficially owned 19,163.9266 shares of Agilent common stock directly and 2,607.6856 shares indirectly through a spouse. The holdings include shares acquired under Agilent’s dividend reinvestment plan and its Employee Stock Purchase Plan, which were obtained in transactions exempt from Section 16 reporting rules.
Agilent Technologies (A) reported insider share transactions by its President and CEO related to equity compensation taxes. On 11/14/2025, the executive surrendered 203 shares of common stock to Agilent at a price of $146.82 per share to cover tax liabilities from vested restricted stock units, leaving 33,245 shares beneficially owned afterward. On the same date, the executive surrendered an additional 276 shares at $146.82 per share for the same tax purpose, resulting in 32,969 shares beneficially owned following these transactions. These are routine tax-withholding transactions under Rule 16b-3 rather than open-market purchases or sales.
Agilent Technologies, Inc. executive reports tax-related share surrender
An Agilent Technologies (A) Senior Vice President reported two small transactions in company common stock on 11/14/2025. The reporting person surrendered 37 shares and 58 shares of Agilent common stock to the company at a price of $146.82 per share to cover tax liabilities arising from the vesting of restricted stock units, in accordance with Rule 16b-3. After these transactions, the executive directly beneficially owns 8,064 shares of Agilent common stock.
Agilent Technologies (A) disclosed a Form 4 for an executive stock transaction involving VP and Corporate Controller Rodney Gonsalves. On 11/14/2025, Gonsalves surrendered 77 shares and 99 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, with both transactions priced at $146.82 per share under Rule 16b-3. After these tax-withholding transactions, he beneficially owned 30,924.6872 shares directly. The filing notes that this direct amount includes 52.6440 shares acquired through Agilent’s dividend reinvestment plan and 76.3520 shares acquired via an employee stock purchase plan in transactions exempt from short-swing profit rules. In addition, 40.192 shares are held indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees.
Agilent Technologies (A) insider transaction: The company’s President and CEO, also a director, exercised 12,490 stock options at $109.86 per share on 11/12/2025 and sold 12,490 common shares at $150 the same day. Following these transactions, the reporting person directly owned 33,448 shares.
The activity was conducted under a Rule 10b5-1 plan adopted on March 28, 2025. The options were granted under the 2018 Stock Plan, originally awarded on November 17, 2020, and became exercisable in four equal annual installments beginning one year after grant, with an expiration date of November 17, 2030.